Imiquimod 5% cream
1413-IMIQ
Phase 3 small_molecule completed
Quick answer
Imiquimod 5% cream for Superficial Basal Cell Carcinoma is a Phase 3 program (small_molecule) at Grace Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Grace Therapeutics
- Indication
- Superficial Basal Cell Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed